Inhibitors of vascular endothelial growth factor in cancer

Cardiovascular and Hematological Agents in Medicinal Chemistry

Volumn 6, Issue 4, 2008, Pages 343-347

  Pourgholami, Mohammad H ^a   Morris, David L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Albendazole; Angiogenesis; Bevacizumab; Cancer; Sorafenib; Tyrosine kinase inhibitors; Vascular endotheal growth factor

Indexed keywords

2 METHOXYESTRADIOL; 2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID; 3 (4 BROMO 2,6 DIFLUOROBENZYLOXY) 5 [3 [4 (1 PYRROLIDINYL)BUTYL]UREIDO] 4 ISOTHIAZOLECARBOXAMIDE; ALBENDAZOLE; ANGIOGENESIS INHIBITOR; BENZIMIDAZOLE DERIVATIVE; BEVACIZUMAB; CARBANILAMIDE DERIVATIVE; CARBOPLATIN; CEDIRANIB; COLCHICINE; CYCLOOXYGENASE 2 INHIBITOR; CYTOTOXIC AGENT; MITOGENIC AGENT; PACLITAXEL; PEGAPTANIB; PROTEIN BCL 2; PROTEIN TYROSINE KINASE INHIBITOR; SEMAXANIB; SORAFENIB; SUNITINIB; UNINDEXED DRUG; VANDETANIB; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3; VATALANIB;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; BLOOD VESSEL PERMEABILITY; CANCER CELL; CANCER CHEMOTHERAPY; CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; COMBINATION CHEMOTHERAPY; DIGESTIVE SYSTEM PERFORATION; DRUG EFFICACY; DRUG ERUPTION; DRUG PROTEIN BINDING; DRUG TARGETING; ENDOTHELIUM CELL; ENZYME RELEASE; EXTRACELLULAR MATRIX; GASTROINTESTINAL SYMPTOM; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; LEUKEMIA; LIVER CELL CARCINOMA; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MICROTUBULE; MONOTHERAPY; NONHUMAN; OVARY CANCER; PROGNOSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; STROMA CELL; UNSPECIFIED SIDE EFFECT;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; NEOPLASMS; PROTEIN KINASE INHIBITORS; TUBULIN MODULATORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 54949156454     PISSN: 18715257     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152508785909528     Document Type: Review

References (77)

1. Warren, B.A. Microvasc. Res., 1970, 2, 443.
2. Ferrara, N.; Kerbel, R.S. Nature, 2005, 438, 967.
3. Dvorak, H.F. J. Thromb. Haemost., 2005, 3, 1835.
4. Folkman, J. Nat. Med., 1995, 1, 27.
5. Folkman, J. Nat. Rev. Drug. Discov., 2007, 6. 273.
6. Carmeliet, P.; Jain, R.K. Nature, 2000, 407, 249.
7. Dvorak, H.F. Am. Pathol., 2003, 162, 1747.
8. Carmeliet, P. Nature, 2005, 438, 932.
9. Folkman, J. Semin. Oncol., 2002, 29, 15.
10. Verheul H.M.; Voest, E.E.; Schlingemann, R.O. J. Pathol., 2004, 202, 5.
11. Zebrowski, B.K.; Yano, S.; Liu, W.; Shaheen, R.M.; Hicklin, D.J.; Putnam, J.B., Jr.; Ellis, L.M. Clin. Cancer Res., 1999, 5, 3364.
12. Zhong, H.; Bowen, J.P. Curr. Med. Chem., 2006, 13, 849.
13. Senger, D.R.; Galli, S.J.; Dvorak, A.M.; Perruzzi, C.A.; Harvey, V.S.; Dvorak, H.F. Science, 1933, 219, 983.
14. Keck, P.J.; Hauser, S.D.; Krivi, G.; Sanzo, K.; Warren, T.; Feder, J.; Connolly, D.T. Science, 1989, 246, 1309.
15. Hu, L.; Hofmann, J.; Zaloudek, C.; Ferrara, N.; Hamilton, T.; Jaffe, R.B. Am. J. Pathol., 2002, 161, 1917.
16. Ferrara, N. Oncologist, 2004, 9, 2.
17. Senger, D.R.; Perruzzi, C.A.; Feder, J.; Dvorak, H.F. Cancer Res., 1936, 46, 5629.
18. Roy, H.; Bhardwaj, S.; Yla-Herttuala, S. FEBS Lett., 2006, 580, 2879.
19. Masood, R.; Cai, J.; Zheng, T.; Smith, D.L; Hinton, D.R.; Gill, P.S. Blood, 2001, 98, 1904.
20. Alon, T.; Hemo, I.; Itin, A.; Pe'er, J.; Stone, J.; Keshet, E. Nat. Med., 1995, 1, 1024.
21. Gerber, H.P.; Dixit, V.; Ferrara, N. J. Biol. Chem., 1998, 273, 13313.
22. Podar, K.; Anderson, K.C. Blood, 2005, 105, 1383.
23. Wilhelm, S.; Carter, C.; Lynch, M.; Lowinger, T.; Dumas, J.; Smith, R.A.; Schwartz, B.; Simantov, R.; Kelley, S. Nat. Rev. Drug Discov., 2006, 5, 835.
24. Dvorak, H.F.; Brown, L.F.; Detmar, M.; Dvorak, A.M. Am. J. Pathol., 1995, 146, 1029.
25. Bates, D.O.; Harper, S.J. Vas. Pharmacol., 2002, 39, 225.
26. Luo, J.C.; Toyoda, M.; Shibuya, M. Cancer Res., 1998, 58, 2594.
27. Byrne, A.T.; Ross, L.; Holash, J.; Nakanishi, M.; Hu, L; Hofmann, J.I.; Yancopoulos, G.D.; Jaffe, R.B. Clin. Cancer Res., 2003, 9, 5721.
28. Pourgholami, M.H.; Cai, Y.Z.; Lu, Y.; Wang, L.; Morris, D.L. Clin. Cancer Res., 2006, 12, 1928.
29. Ferrara, N.; Davis-Smyth, T. Endocr. Rev., 1997, 18, 4.
30. Carmeliet, P. Oncology, 2005, 69(Suppl 3). 4.
31. Dias, S.; Hattori, K.; Heissig, B.; Zhu, Z.; Wu, Y.; Witte, L.; Hicklin, D.J.; Tateno, M.; Bohlen, P.; Moore, M.A.; Rafü, S. Proc. Natl. Acad. Sci. USA, 2001, 98, 10857.
32. Nilsson, M.; Heymach, J.V. J. Thorac. Oncol., 2006, 1, 768.
33. Gimbrone, M.A., Jr.; Leapman, S.B.; Cotran, R.S.; Folkman, J. J. Exp. Med., 1972, 136, 261.
34. Morabito, A.; De Maio, E.; Di Maio, M.; Normanno, N.; Perrone, F., Oncologist, 2006, 11, 753.
35. Hanrahan, E.O.; Heymach, J.V. Clin. Cancer Res., 2007, 13, 4617.
36. Duyndam, M.C.; Van Berkel, M.P.; Dorsman, J.C.; Rockx, D.A.; Pinedo, H.M.; Boven, E. Biochem. Pharmacol, 2007, 74, 191.
37. Kim, K.J.; Li, B.; Winer, J.; Armanini, M.; Gillett, N.; Phillips, H.S.; Ferrara, N. Nature, 1993, 362, 841.
38. Gerber, H.P.; Kowalski, J.; Sherman, D.; Eberhard, D.A.; Ferrara, N. Cancer Res., 2000, 60, 6253.
39. Cannistra, S.A.; Matulonis, U.A.; Penson, R.T.; Hambleton, J.; Dupont, J.; Mackey, H.; Douglas, J.; Burger, R.A.; Armstrong, D.; Wenham, R.; Mcguire, W. J. Clin. Oncol., 2007, 25, 5180.
40. Ferrara, N. J. Mol. Med., 1999, 77, 527.
41. Kayton, M.L.; Rowe, D.H.; O'toole, K.M.; Thompson, R.B.; Schwarz, M.A.; Stolar, C.J.; Kandel, J.J. J. Pediatr. Surg., 1999, 34, 743.
42. Rowe, D.H.; Huang, J.; Kayton, M.L.; Thompson, R.; Troxel, A.; O'toole, K.M.; Yamashiro, D.; Stolar, C.J.; Kandel, J.J. J. Pediatr. Surg., 2000, 35, 30.
43. Simiantonaki, N.; Taxeidis, M.; Jayasinghe, C.; Kirkpatrick, C.J. Anticancer Res., 2007, 27, 3245.
44. Verheul, H.M.; Pinedo, H.M. Nat. Res. Cancer, 2007, 7, 475.
45. Riely, G.J.; Miller, V.A. Clin. Cancer Res., 2007, 13, 4623.
46. Schenone, S.; Bondavalli, F.; Botta, M. Curr. Med. Chem., 2007, 14, 2495.
47. Dev, I.K.; Dornsife, R.E.; Hopper, T.M.; Onori, J.A.; Miller, C.G.; Harrington, L.E.; Dold, K.M.; Mullin, R.J.; Johnson, J.H.; Crosby, R.M.; Truesdale, A.T.; Epperly, A.H.; Hinkle, K.W.; Cheung, M.; Stafford, J.A.; Luttrell, D.K.; Kumar, R. Br. J. Cancer, 2004, 91, 1391.
48. Sessa, C.; Vigano, L.; Grasselli, G.; Trigo, J.; Marimon, I.; Llado, A.; Locatelli, A.; Telmini, N.; Marsoni, S.; Gianni, L. Eur. J. Cancer, 2006, 42, 171.
49. Grandinetti, C.A.; Goldspiel, B.R. Pharmacotherapy, 2007, 27, 1125.
50. Zhong, H.; Bowen, J.P. Curr. Top. Med. Chem., 2007, 7, 1379.
51. Faivre, S.; Delbaldo, C.; Vera, K.; Robert, C.; Lozahic, S.; Lassau, N.; Bello, C.; Deprimo, S.; Brega, N.; Massimini, G.; Armand, J.P.; Scigalla, P.; Raymond, E. J. Clin. Oncol., 2006, 24, 25.
52. Homsi, J.; Daud, A.I. Cancer Control, 2007, 14, 285.
53. Sandler, A. Clin. Cancer Res., 2007, 13, 4613.
54. Checchi, P.M.; Nettles, J.H.; Zhou, J.; Snyder, J.P.; Joshi, H.C. Trends Pharmacol. Sci., 2003, 24, 361.
55. Tsuzuki, Y.; Fukumura, D.; Oosthuyse, B.; Koike, C; Carmeliet, P.; Jain, R.K. Cancer Res., 2000, 60, 6248.
56. Escuin, D.; Kline, E.R.; Giannakakou, P. Cancer Res., 2005, 65, 9021.
57. Marti, H.H.; Risau, W. Proc. Natl. Acad. Sci. USA, 1998, 95, 15809.
58. Mabjeesh, N.J.; Escuin, D.; Lavallee, T.M.; Pribluda, V.S.; Swartz, G.M.; Johnson, M.S.; Willard, M.T.; Zhong, H; Simons, J.W.; Giannakakou, P. Cancer Cell., 2003, 3, 363.
59. Liao, D.; Johnson, R.S. Cancer Metastasis Rev., 2007, 26, 281.
60. Mabjeesh, N.J.; Amir, S. Histol. Histopathol., 2007, 22, 559.
61. Ettenson, D.S.; Gotlieb, A.I. Lab. Invest., 1992, 66, 722.
62. Belotti, D.; Vergani, V.; Drudis. T.; Borsotti, P.; Pitelli, M.R.; Viale, G.; Giavazzi, R.; Taraboletti, G. Clin. Cancer Res., 1996, 2, 1843.
63. Pasquier, E.; Honore, S.; Braguer, D. Drug Resist. Updat., 2006, 9, 74.
64. Stafford, S.J; Schwimer, J.; Anthony, C.T.; Thomson, J.L.; Wang, Y.Z.; Woltering, E.A. J. Surg. Res., 2005, 125, 104.
65. Pourgholami M.H.; Woon, L, Almajd, L; Akhter, J.; Bowery, P.; Morris, D.L. Cancer Lett., 2001, 165, 43.
66. Pourgholami, M.H.; Akhter, J.; Wang, L.; Lu, Y.; Morris, D.L. Cancer Chemother. Pharmacol., 2005, 55, 425.
67. Morris, D.L.; Jourdan. J.L.; Pourgholami, M.H. Oncology, 2001, 61, 42.
68. Ireland, C.M.; Gull, K.; Gutteridge, W.E.; Pogson, C.I. Biochem. Pharmacol., 1979, 28, 2680.
69. Lacey, E.; Watson, T.R. Biochem. Pharmacol., 1985, 34, 1073.
70. Viger, A.; Dervan, P.B. Bioorg. Med. Chem., 2006, 14, 8539.
71. Lynch, T., Jr.; Kim, E. Lung Cancer, 2005, 50(Suppl. 2). S25.
72. Kerbel, R.S.; Kamen, B.A. Nat. Rev. Cancer, 2004, 4, 423.
73. Kamen, B.A.; Glod, J.; Cole, P.D. J. Pediatr. Hematol. Oncol., 2006, 28, 325.
74. Hu, L.; Hofmann, J.; Holash, J.; Yancopoulos, G.D.; Sood, A.K.; Jaffe, R.B. Clin. Cancer Res., 2005, 11, 6966.
75. Brown, D.M.; Regillo, C.D. Am J. Ophthalmol., 2007, 144, 627.
76. Takeda, A.L.; Colquitt, J.; Clegg, A.J.; Jones, J. Br. J. Ophthalmol., 2007, 91, 1177.
77. Kaiser, P.K.; Brown, D.M.; Zhang, K.; Hudson, H.L.; Holz, F.G.; Shapiro, H.; Schneider, S.; Acharya, N.R. Am. J. Ophthalmol., 2007, 144, 850.